Sex and Gender Disparities in Melanoma

Por Maria Bellenghi, Rossella Puglisi, Giada Pontecorvi, Alessandra De Feo, Alessandra Carè, Gianfranco Mattia
Publicado em 2020-07-01

“<i>Bridging the Gap</i>” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Er...

Por Donato Gemmati, Katia Varani, Barbara Bramanti, Roberta Piva, Gloria Bonaccorsi, Alessandro Trentini, Maria Cristina Manfrinato, Veronica Tisato, Alessandra Carè, Tiziana Bellini
Publicado em 2019-12-01

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

Por Simona Caporali, Adriana Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar, Gian Carlo Antonini Cappellini, Nadia Felli, Alessandra Carè, Ulrich Pfeffer, Stefania D’Atri
Publicado em 2019-06-01

miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma.

Por Nadia Felli, Federica Felicetti, Anna Maria Lustri, M Cristina Errico, Lisabianca Bottero, Alessio Cannistraci, Alessandra De Feo, Marina Petrini, Francesca Pedini, Mauro Biffoni, Ester Alvino, Massimo Negrini, Manuela Ferracin, Gianfranco Mattia, Alessandra Carè
Publicado em 2013-01-01